The effect of CYP2C19 genetic polymorphism and non-genetic factors on clopidogrel platelets inhibition in East Asian coronary artery disease patients

被引：13
作者：
Amin, Arwa M. [1 ]
Chin, Lim Sheau [1 ]
Noor, Dzul Azri Mohamed [1 ]
Mostafa, Hamza [1 ]
Kader, Muhamad Ali S. K. Abdul [1 ,2 ]
Hay, Yuen Kah [1 ]
Ibrahim, Baharudin [1 ]
机构：
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Hosp Pulau Pinang, Cardiol Dept, George Town, Penang, Malaysia
来源：
THROMBOSIS RESEARCH | 2017年 / 158卷
关键词：
CYP2C19; Clopidogrel; Dual antiplatelet therapy (DAPT); Coronary artery disease patients; VerifyNow; High on treatment platelets reactivity; CLINICAL-OUTCOMES; THERAPY; IMPACT; RISK;
D O I：
10.1016/j.thromres.2017.07.032
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：22 / 24
页数：3
相关论文
共 13 条
  • [1] The journey of Malaysian NCVD-PCI (National Cardiovascular Disease Database-Percutaneous Coronary Intervention) Registry: A summary of three years report
    Ahmad, Wan Azman Wan
    Ali, Rosli Mohd
    Khanom, Mehrunnissa
    Han, Chee Kok
    Bang, Liew Houng
    Yip, Alan Fong Yean
    Ghazi, Azmee Mohd
    Ismail, Omar
    Zambahari, Robaayah
    Hian, Sim Kui
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 165 (01) : 161 - 164
  • [2] The association of cigarette smoking with enhanced platelet inhibition by clopidogrel
    Bliden, Kevin P.
    DiChiara, Joseph
    Lawal, Lookman
    Singla, Anand
    Antonino, Mark J.
    Baker, Brian A.
    Bailey, William L.
    Tantry, Udaya S.
    Gurbel, Paul A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (07) : 531 - 533
  • [3] Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting
    Cuisset, Thomas
    Frere, Corinne
    Quilici, Jacques
    Morange, Pierre-Emmanuel
    Nait-Saidi, Lyassine
    Carvajal, Joseph
    Lehmann, Agnes
    Lambert, Marc
    Bonnet, Jean-Louis
    Alessi, Marie-Christine
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) : 1339 - 1345
  • [4] Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation
    Geisler, Tobias
    Anders, Nicole
    Paterok, Maria
    Langer, Harald
    Stellos, Konstantinos
    Lindemann, Stephan
    Herdeg, Christian
    May, Andreas E.
    Gawaz, Meinrad
    [J]. DIABETES CARE, 2007, 30 (02) : 372 - 374
  • [5] Comparison of VerifyNow-P2Y12 test and flow cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?
    Godino C.
    Mendolicchio L.
    Figini F.
    Latib A.
    Sharp A.S.P.
    Cosgrave J.
    Calori G.
    Cera M.
    Chieffo A.
    Castelli A.
    Maseri A.
    Ruggeri Z.M.
    Colombo A.
    [J]. Thrombosis Journal, 7 (1)
  • [6] The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response
    Harmsze, Ankie M.
    Robijns, Karen
    Van Werkum, Jochem W.
    Breet, Nicoline J.
    Hackeng, Christian M.
    ten Berg, Jurrien M.
    Ruven, Hendrik J. T.
    Klungel, Olaf H.
    de Boer, Anthonius
    Deneer, Vera H. M.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 103 (05) : 920 - 925
  • [7] Chronic kidney disease - Is it a true risk factor of reduced clopidogrel efficacy in elderly patients with stable coronary artery disease?
    Leng, Wen-Xiu
    Ren, Jun-Wei
    Cao, Jian
    Cong, Yu-Long
    Cui, Hua
    Hu, Guo-Liang
    Hu, Qing-Qing
    Niu, Hui
    Fan, Li
    [J]. THROMBOSIS RESEARCH, 2013, 131 (03) : 218 - 224
  • [8] CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention
    Mejin, Melissa
    Tiong, Wen Ni
    Lai, Lana Yin Hui
    Tiong, Lee Len
    Bujang, Adam Mohamad
    Hwang, Siaw San
    Ong, Tiong Kiam
    Fong, Alan Yean Yip
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (04) : 621 - 628
  • [9] Mostafa A. M. Amin, 2016, GLOB HEART, V11
  • [10] Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting
    Pankert, Mathieu
    Quilici, Jacques
    Loundou, Anderson Diendonne
    Verdier, Valentine
    Lambert, Marc
    Deharo, Pierre
    Bonnet, Guillaume
    Gaborit, Benedicte
    Morange, Pierre Emmanuel
    Valero, Rene
    Dutour, Anne
    Bonnet, Jean-Louis
    Alessi, Marie-Christine
    Cuisset, Thomas
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (01) : 54 - 59
12